M. Zughaib, B. Basharat and D. Small (2023). A Case of STEMI-Induced Euglycemic Diabetic Ketoacidosis in a Patient Receiving a Sodium Glucose Cotransporter-2 Inhibitor. JACC. Case reports, 11, 101792. https://doi.org/10.1016/j.jaccas.2023.101792

PubMed 37077449

[Abstract]
A 54-year-old female on sodium glucose cotransporter-2 inhibitor presented with ST-segment elevation myocardial infarction, nausea, and vomiting. Percutaneous intervention was performed to the right coronary artery. The chest pain resolved, but she continued to experience nausea and vomiting. Euglycemic diabetic ketoacidosis was diagnosed secondary to the ST-segment elevation myocardial infarction. After treatment for euglycemic diabetic ketoacidosis, her nausea and vomiting had resolved. (Level of Difficulty: Beginner.).